A real-time reverse transcription-polymerase chain reaction (RT-PCR) assay was developed for the detection of bluetongue virus (BTV) in blood samples. A combination of primers specific for a highly conserved region in RNA segment 5 (based on Mediterranean BTV sequences) and a DNA probe bound to 5Ј-Taq nuclease-3Ј minor groove binder (TaqMan᭧ MGB) was used to detect a range of isolates. This real-time RT-PCR assay could detect 5.4 ϫ 10 Ϫ3 tissue culture infectious doses (TCID 50 ) of virus per milliliter of sample, which was comparable to our current BTV diagnostic nested RT-PCR assay. The assay detected all recent Mediterranean isolates (including serotypes 2, 4, and 16), BTV vaccine strains for serotypes 2 and 4, and 15 out of the 24 BTV reference strains available (all serotypes), but did not detect the related orbiviruses epizootic hemorrhagic disease and African horse sickness viruses. Following assay evaluation, the ability of this assay to identify BTV in recent isolates (2003, 2004) from ovine and bovine samples from an epizootic outbreak in Spain was also tested. Minor nucleotide changes (detected by sequencing viral genomes) within the probebinding region were found to have a profound effect on virus detection. This assay has the benefits of being fast and simple, and the 96-well format enables large-scale epidemiological screening for BTV, especially when combined with a high-throughput nucleic acid extraction method.
Introduction
Bluetongue virus (BTV) is the prototype member of the genus Orbivirus within the family Reoviridae, and its primary route of transmission among sheep and other ruminants is via the arthropod vector Culicoides (midge). Cattle are suspected to be the predominant reservoir for this virus, as BTV infection is asymptomatic in cattle, but results in a prolonged viremia. 8, 9 The BTV genome consists of 10 double-stranded RNA segments that encode 7 structural proteins (VP1 to VP7) and 4 nonstructural (NS1, NS2, NS3, and NS3a) proteins. Not only is there marked genetic variation among the 24 known BTV serotypes, but also among the virus strains within each serotype. 7, 12 In addition, this group of viruses exhibits genetically and geo-From the Laboratorio Central de Veterinaria, Algete, Spain (Jiménez-Clavero, Agüero, San Miguel, Mayoral, Cruz López, Ruano, Romero, Gómez-Tejedor), and Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise ''G. Caporale,'' Teramo, Italy (Monaco, Polci, Savini). 1 Corresponding author: Miguel Angel Jiménez-Clavero, Departamento de Enfermedades Emergentes, Laboratorio Central de Veterinaria, Ctra. Algete km 8, 28110, Algete, Madrid, Spain. graphically distinct evolutionary lineages, or topotypes, 11, 12 allowing the differentiation of BTV variants from different origins, even within the same serotype. The emergence of new BTV variants is considered to be driven by reassortment of RNA segments (i.e., genetic shift), 24, 30, 31 whereas individual gene segments evolve independently by genetic drift due to immunological pressure from the infected host. 6 The distribution of Bluetongue disease is determined by the geographic distribution of the arthropod vector and includes both tropical and temperate areas, including Africa, southern Asia, Australia, the Middle East, and the Americas. Due to the serious socioeconomic consequences of BTV outbreaks on the international trade of animals and animal products, it has been included in the Office International des Epizooties (OIE) list of notifiable diseases (formerly List A). 25 Epizootic episodes of BTV, which occur infrequently, result in large losses through required control measures of infected and cohoused livestock. In autumn 2003, several outbreaks of BTV serotype 4 virus were reported in the western Mediterranean region (Corsica, Sardinia, and Menorca) (OIE-Handistatus II, http://www.oie.int/hs2 [accessed June 2005]) and BTV serotype 2 outbreaks had been previously reported in this area in 1999-2000. 13, 22, 38 Although BTV had never been detected in this area before 1999, the presence of the Culicoides vectors 23, 32, 37 and theoretical modeling based on climate data 37 and satellite remote sensing 35 predicted that this region was at high risk for BTV epizootic infections. In autumn 2004, these predictions were borne out by new epizootic outbreaks of BTV serotype 4, first reported in northern Morocco, and soon after in the Iberian Peninsula, which had been free of BTV since the 1950s. Other areas of the Mediterranean region where BTV outbreaks have been reported in the last 7 years include Albania, Algeria, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Greece, Israel, Italy (mainland), Kosovo, Macedonia, Serbia and Montenegro, Tunisia, and Turkey (OIE-Handistatus II, http://www.oie.int/hs2 [accessed June 2005] ).
The speed of the assays to detect BTV is directly related to the ability to detect viremic animals and therefore to limiting the spread of disease. Viremia can be demonstrated in blood of infected animals by either virus isolation or nucleic acid detection methods. Although virus isolation in embryonated chicken eggs is reliable and sensitive, it is technically cumbersome and requires significantly longer to yield a result than nucleic acid-based detection assays. For these reasons, the latter have become the method of choice for BTV detection. Several reverse transcription-polymerase chain reaction (RT-PCR) methods have previously been described, [1] [2] [3] [4] 10, 15, 17, 33 and the BTV segment 5 (encoding the NS1 protein) is the most commonly targeted gene due its high degree of conservation across BTV serogroups (segment 10 has also been used). Current RT-PCR methods for BTV detection are rapid and show satisfactory sensitivity and specificity; however, this methodology is not well suited to highthroughput analysis, limiting its use in large-scale epidemiological surveillance. For these reasons, we have examined the use of real-time fluorogenic RT-PCR methodologies in a 96-well format for high-throughput sample monitoring.
We developed a real-time fluorogenic RT-PCR method using a 5Ј-Taq nuclease-3Ј minor groove binder 18 (TaqMan᭧ MGB) DNA probe for the detection of BTV in a 96-well format. We then evaluated the usefulness of the assay using laboratory and previously characterized BTV serotypes (isolated from western Mediterranean outbreaks) and tested the assay against samples from recent Spanish BTV outbreaks.
Materials and methods

Viruses, vaccines, cells, and virus propagation in cell cultures
The following BTV strains were used in this study: prototype strains for all 24 BTV serotypes from the European Union (EU) reference laboratory for BTV (Pirbright, UK) (http://www.iah.bbsrc.ac.uk/dsRNAvirusproteins/ReoID/ BTV-isolates.htm [accessed June 2005]); field isolates from the Mediterranean region: SPA2000 (Majorca, Spain) and SAD2000 (Sardinia, Italy), both belonging to serotype 2; SPA2003 (Menorca, Spain), SAD2003 (Sardinia, Italy), SPA2004 (Cádiz, Spain), and MOR2004 (Morocco), belonging to serotype 4; ITL2002 (Puglia, Italy), belonging to serotype 16; and live attenuated monovalent vaccines for serotypes 2 and 4 (OBP a , Onderstepoort, South Africa). Viruses were propagated and virus concentrations were determined by microtitration assay 28 using Vero cells, which were cultured in Eagle medium (EMEM) supplemented with Lglutamine, antibiotics (100 U/ml penicillin, 100 g/ml streptomycin) and 5% fetal calf serum. Assay specificity was assessed using phylogenetically or symptomatically related viruses (or both): African horse sickness virus (AHSV serotype 4, isolate SPA'87, from the National Reference Laboratory for African Horse sickness virus, Central Veterinary Laboratory, Algete, Spain); epizootic hemorrhagic disease virus (EHDV North American prototype serotypes 2 and 4) c ; foot-and-mouth disease virus, FMDV serotypes A, O, C, Asia-1, SAT-1, SAT-2, and SAT-3 d ; and contagious ecthyma virus (field isolate, Central Veterinary Laboratory, Algete, Spain, unpublished). 
Samples
Sample processing and total nucleic acid extraction
Single tube-spin protocol. Five hundred microliters of each blood sample was lysed with 1 ml of sterile water, incubated for 10 minutes on ice, and then centrifuged at 16,000 ϫ g for 5 minutes at 4ЊC. The supernatant was then removed and the pellet was resuspended in 0.2 ml of binding buffer that had been provided by the High Pure Viral (HPV) nucleic acid extraction kit. e The total RNA extraction was completed as indicated in the manufacturer's instructions using 50 l as the elution volume. Tissue samples (approximately 0.5 g) were homogenized in 1 ml of phosphate-buffered saline (PBS) and following a 10-minute centrifugation at 16,000 ϫ g, 1 volume (0.2 ml) of supernatant was mixed with 1 volume of binding buffer (from the same kit as above), and nucleic acid extraction was achieved in the same way. Total RNA extraction of infected cell culture supernatants containing BTV serotypes or control viruses at titers of at least 1 ϫ 10 4 TCID 50 /ml (starting volume, 20-200 l), was achieved in the same way.
Nucleic acid extraction in 96-well format. Two separate formats were used: 1) The Nucleospin Multi-96 virus nucleic acid extraction kit f was applied as follows: 0.1 ml of blood and 0.2 ml of distilled water was added to each well in the 96-well lysis microplate. Following centrifugation as above, the cell pellet that was resuspended in 0.4 ml of RAV1 buffer plus 20 l (1 g/l) of proteinase K and RNA extraction completed according to the manufacturer's instructions. 2) High Pure viral nucleic acid extraction kit e in 96-well format (HPV-96): samples were prepared essentially according to the manufacturer's instructions except that Whatman 96-well Unifilter microplates g were used instead of the spin columns provided in the kit. The final protocol was as follows: 0.1ml blood samples were lysed in the same way as described above for Nucleospin Multi-96, but using a Whatman 800l round-bottom 96-well Uniplate. h The cell pellet was resuspended in 0.1 ml of binding buffer plus 20 l (1 g/l) of proteinase K (provided in the kit), and subjected to a 10minute incubation at 72ЊC, followed by the addition of 50 l of isopropanol to each well. After gentle mixing, the entire contents of each well was removed from the 96-well Uniplate, transferred to a Unifilter microplate, g and placed over another 800-l round-bottom 96-well Uniplate h for collection of the filtrates, following centrifugation for 15 minutes at 2,250 ϫ g. The filtrates were discarded and 250 l of inhibitor buffer (provided in the kit) was added to each filter well and the plate was centrifuged for 4 minutes at 2,250 ϫ g. The filter wells were then washed twice with 250 l of wash buffer (provided in the kit) and subjected to 2 centrifugation steps for 4 minutes and 15 minutes at 2,250 ϫ g. The filtrate was discarded and the filters were then dried by centrifugation at 2,250 ϫ g for a further 5 minutes. The recovery plate was changed to a Whatman 250-l V-bottom 96-well Uniplate, i and 50 l of nuclease-free water was added to each filter well and the plate centrifuged for 10 minutes at 2,250 ϫ g to elute the nucleic acids from the filters. The eluted nucleic acids were either immediately analyzed by RT-PCR or stored at Ϫ20ЊC for future use.
Comparison between single-tube and 96-well nucleic acid extraction methods. BTV-seropositive blood samples (1 from sheep, 2 from cattle) were serially diluted in BTVseronegative blood from the same species, whereas the vaccine was diluted in PBS. All samples were subjected to nucleic acid extraction in parallel.
Nested RT-PCR for BTV and RT-PCR for other viruses
Nested RT-PCR for BTV detection was performed according to the method described by Aradaib et al. 2 We also used PCR or RT-PCR methods already described for the detection of African horse sickness virus, 34 epizootic hemorrhagic disease virus, 2 contagious ecthyma virus, 14 and footand-mouth disease virus. 29 In the case of control viruses, nucleic acid extraction was performed as described in the single tube-spin protocol (see above).
Sequence analysis
To analyze the detection range of the real-time RT-PCR method in more detail, the RNA regions corresponding to nucleotide positions 316-790 (numbered according to GenBank AY137387) within segment 5 were sequenced for the following isolates: BTV-2 SPA2000, BTV-4 SPA2003, BTV-4 SPA2004, BTV-4 MOR2004, BTV-4 ITL2002, BTV-4 (vaccine strain a ), BTV-4 reference strain, BTV-16 reference strain, BTV-24 reference strain, BTV-19 reference strain, BTV-10 reference strain, BTV-13 reference strain, and BTV-7 reference strain. RNA sequence was determined following amplification by nested RT-PCR, 2 which was bidirectionally sequenced using the inner primers of the nested reaction, the Big Dye Terminator (version 3.1) Cycle Sequencing Kit, j and an ABI 3730 XL DNA Analyzer. k Electropherograms were analyzed using the Sequencing Analysis (version 5.1) software l and sequences have been submitted to GenBank under accession numbers AY741396 (BTV-2 SPA2000), AY741397 (BTV-4 SPA2003), DQ098094 (BTV-4 ITL2002), DQ098092 (BTV-4 MOR2004), DQ098093 (BTV-4 SPA2004), DQ098095 (BTV-4 vaccine strain a ), DQ098096 (BTV-4 reference strain), DQ098097 (BTV-7 reference strain), DQ098098 (BTV-10 reference strain), DQ098099 (BTV-13 reference strain), DQ098100 (BTV-16 reference strain), DQ098101 (BTV-19 reference strain), and DQ098102 (BTV-24 reference strain). The sequences obtained were aligned with the following BTV NS1 sequences available in GenBank: AY137387 (BTV-2 Corsica 2002), Y00422 (BTV-10, US prototype strain), X17041 (BTV-17, US prototype strain), M97681 (BTV-11, US prototype strain), M97762 (BTV-13, US prototype strain), M97680 (BTV-2, US prototype strain), AY462225 (BTV-2 KN, Taiwan), and X56735 (BTV-20, Australia) using the CLUSTAL W 1.6 program. 36
Real-time fluorogenic RT-PCR
Oligonucleotide primers and a Taqman-MGB fluorogenic probe were designed using Primer Express (version 2.0.0) software m based on the BTV-2 (SPA2000) and BTV-4 (SPA2003) isolate sequences; however, homology to the same region of the BTV genome (GenBank accession numbers AY137387, AY138895, M97762, X17041, X15891, Y00422, M97681, M97680, and X56735) were also confirmed. The CLUSTAL W 1.6 program 36 was used to design conserved sequence primers: forward (5Ј-GTTGAGAGA-CAAATTAACACATGTCC-3Ј) and reverse (5Ј-AATGCT TCGCAAAATCATCCAT-3Ј). These primers amplified a region comprising nucleotides 606-723 of BTV segment 5, and a fluorogenic TaqMan-MGB probe (6-FAM-CGATT-CAGCTGATCAAT-MGB) was designed to hybridize nucleotides 676-692 (nucleotide position numbering according to the AY137387 sequence). The final protocol consisted of an initial denaturation step during which primers (final concentration: 0.5 M each) and viral RNA (2 l) were heated at 95ЊC for 5 minutes in a volume of 7 l of RNAase-free water, and then chilled on ice. This denaturation step was followed by the addition of 18 l containing (per reaction) The reactions were analyzed in 96-well optical PCR plates using an ABI PRISM 7000 Sequence Detection System (SDS o ) apparatus and the SDS 7000 (version 1.1) software p . Reverse transcription was carried out at 48ЊC for 25 minutes followed by 10 minutes at 95ЊC (''hot start'') and 40 PCR cycles of 15 seconds at 95ЊC and 1 minute at 61ЊC (total reaction time 2 hours 11 minutes). Samples were considered positive for BTV if they yielded Ct values lower than 40 (threshold set automatically following the instructions of the SDS 7000 analysis software, version 1.1). The sensitivity of the fluorogenic real-time RT-PCR assay was assessed using 10-fold dilutions from the control BTV-2 isolate RNA (SPA2000 isolate), comparing detection of viral extract for both real-time fluorogenic RT-PCR and nested RT-PCR analysis in parallel.
Sensitivity was determined as the highest dilution giving a positive result: for nested RT-PCR this was the highest dilution at which a band was visible on an ethidium bromide-stained gel; for real-time RT-PCR this was the highest dilution to yield a Ct value below 40. All determinations were confirmed by repeating the experiment at least once. The sensitivity of the assay including the RNA extraction was also assessed by repeating the above experiment on 10fold dilutions of the viral stock, which were then processed for nucleic acid extraction and analyzed by both the realtime and nested RT-PCR methods.
Results
Detection of BTV by a new real-time RT-PCR method was compared with an existing nested RT-PCR method (Fig. 1) . Both methods were able to detect a 10 Ϫ5 dilution of the BTV RNA (equivalent to 0.0054 TCID 50 /ml of sample) extracted from 1,080 TCID 50 of cell-cultured BTV serotype 2 (SPA2000). As shown in Fig. 2 , the detection achieved by the real-time RT-PCR assay showed a linear relationship between signal and the concentration of template present in the sample (correlation coefficient of 0.9948, and a slope of Ϫ3.334) over a range of 10 2 to 10 Ϫ3 TCID 50 /ml. To assess whether the nucleic acid extraction step affected the performance of the method, 10-fold dilutions of the viral stock (instead the purified RNA) were also analyzed. A comparable level of sensitivity (0.001 TCID 50 /ml) and linearity (dynamic range, 10 2 to 10 Ϫ3 ; r 2 , 0.9941; slope, Ϫ3.592) was obtained, indicating that the nucleic acid extraction does not significantly affect the overall performance of the method, at least with this type of sample.
The specificity of the new method was determined by analyzing reference BTV isolates from all 24 serotypes (obtained from the EU reference laboratory for BTV disease, Pirbright, UK), as well as vaccine strains (OBP, Onderstepoort, South Africa) and field variants isolated in recent years from the Mediterranean region. We also determined whether our real-time RT-PCR method cross-reacted with other members of the Orbivirus genus (AHSV serotype 4, EHDV serotypes 2 and 4); viruses that cause symptoms similar to bluetongue (contagious ecthyma virus, a member of Poxviridae); or foot-and-mouth disease virus (serotypes A, O, C, Asia, SAT1, SAT2, and SAT3; Picornavirus family) ( Table 1) . The real-time RT-PCR assay detected all recent BTV field variants from the Mediterranean region (serotypes 2, 4, and 16); vaccine strains from BTV serotypes 2 and 4, and 15 out of 24 serotype BTV reference strains. No cross-reactivity was observed for non-BTV virus samples by our real-time RT-PCR assay, regardless of whether they belong to the Orbivirus genus or have similar pathogenic sequelae. However, the integrity of the nucleic acids isolated from the negative control viruses was confirmed by positive results for their own specific PCR or RT-PCR detection assays (not shown).
Although the BTV serotype 4 reference strain was not detected by our real-time RT-PCR assay, all other BTV serotype 4 field isolates and the vaccine strain were detected (Table 1) . Similarly, a field isolate of BTV serotype 16 was detected even though the reference strain was not ( Table 1 ). These results indicate that the inability to detect the reference strains does not rule out its effectiveness at detecting these serotypes in the field. The failure of our assay to detect some BTV isolates was investigated by comparing the sequence of the primer and probe target regions from undetected BTV isolates and a selection of the detected viruses ( Table 2) . Although the primer binding regions were found to allow 1 (e.g., BTV-2 SPA2000) or 2 (e.g., BTV-4 and BTV-2 vaccine strains, BTV-16 ITL2002) mismatches without loss of detection, higher stringency was found for the probe-binding sequence, as a single mismatch resulting in loss of detection for 1 isolate. The lowest number of nucleotide sequence changes that rendered a strain nondetectable was found in the BTV-4 reference strain, for which a single mismatch in the probe region and 2 more in the forward (5Ј) primer resulted in a loss of detection. In other nondetected reference strains (serotypes 7, 10, 13, 16, 19, and 24), the differences in nucleotide sequence ranged from 1 to 3 mismatches in the forward (5Ј) primer, 1 to 5 mismatches in the probe, and at least 1 mismatch in the reverse (3Ј) primer. It is remarkable that there was a low homology in the target region between the BTV-16 reference strain and the BTV-16 field isolate used in this study. Table 2 shows the nucleotide sequence alignments of BTV serotypes used in this study, but also includes the available sequences for prototype strains from US BTV serotypes, BTV-2 from Taiwan, and BTV-20 from Australia. Given the homology, we would expect viruses showing 100% identity within the probe region (US BTV-11, -13, and -17) and almost complete nucleotide sequence identity within the primer regions would be detected, whereas those BTV strains showing at least 1 mismatch within the probe region (US BTV-2, and BTV-10, Australian BTV-20, and Taiwan BTV-2) would likely remain undetected. These expectations are supported by a much larger number of mismatches in the primer and probe regions in published sequences for EHDV and AHSV (not shown), which were not detected by our real-time RT-PCR assay ( Table 1) .
To assess the performance of the new BTV detection method under normal diagnostic laboratory conditions, 76 sheep and 21 cattle blood samples from the 2003 Menorca outbreak (previously identified as BTVpositive by the nested RT-PCR method) were analyzed by real-time fluorogenic RT-PCR. In addition, spleen, heart blood, and gut homogenates from a symptomatic sheep that died as a consequence of BTV disease in this outbreak were also tested. As a control, blood samples from 50 BTV-seronegative sheep in BTV-free areas were also tested by nested RT-PCR and the new real-time fluorogenic RT-PCR. Similarly, 300 BTV-seronegative blood samples collected from sentinel cattle in BT-free areas during the 2004 Spanish BTV surveillance program were also tested. As shown in Table  3 , there was complete agreement between the results obtained with both nested and real-time fluorogenic RT-PCR methods. All 97 BTV blood samples found positive by the nested RT-PCR assay were also positive by the real-time fluorogenic RT-PCR method. BTV was detected by both methods from spleen and heart blood, but not gut tissue samples. All BTV-negative samples yielded negative results in both assays (i.e., a zero false-positive rate).
The real-time fluorogenic RT-PCR method can be performed in a 96-well format, and this feature opens the possibility of using RT-PCR methodology in the high-throughput screening of field samples. As nucleic 
* Nucleotide position (numbering according to GenBank AY137387 sequence). † Isolates marked as ''VAC'' are vaccine strains; ''REF'' are the prototype strains from the EU reference collection; ''US'' are US prototype strains, ''Taiw'' is a BTV-2 isolate from Taiwan, and ''AUS'' is the Australian BTV-20 isolate. , and a control BTV-2 attenuated vaccine isolate were subjected to nucleic acid extraction by the 3 methods in parallel, and analyzed by real-time RT-PCR for BTV RNA. As shown in Table 4 , the results obtained with both high-throughput RNA isolation methods were comparable to those obtained with the conventional single-tube method; if differences in start volume and elution volumes are taken into account, the high-throughput methods appear to have a slightly higher yield than the single spin-column protocol ( Table 4 ). However, Ct values for 1 of the bovine blood samples (cattle blood-1) and the vaccine control were higher than expected at the higher dilutions for all RNA extraction methods, suggesting that further op-timization of the nucleic acid extraction step may be required for these types of samples. These findings were confirmed by reanalysis on a separate day. which has reached as high as 2,635 samples in a single week.
Discussion
Real-time RT-PCR methods (especially those based on fluorogenic probe hybridization, such as TaqMan probes, 19 molecular beacons, 20 and fluorescence resonance energy transfer (FRET) probes 26 ) are gaining popularity in the diagnosis of animal viral diseases. As well as providing higher sensitivity and comparable, or even higher, specificity than traditional nucleic acid detection methods, they are much faster and less cumbersome because they do not require electrophoresis in agarose gels. In addition, some real-time instruments allow the use of 96-well plate formats, which further increases the capacity and speed of analysis. The BTV diagnostic assay developed in this study is suitable for screening large numbers of samples consistent with those analyzed in recent BTV outbreaks. The only real-time RT-PCR method for BTV previously described in the literature is a recent protocol that restricted its analysis to the differentiation of vaccine and field variants of a single BTV serotype (BTV-2). 26 When attenuated BTV vaccines are used to protect livestock from BTV infection, the ability to distinguish between wild-type and vaccine strains of BTV makes it possible to know whether an RT-PCR positive result is derived from an acquired wild-type virus or is the result of vaccination. While the real-time RT-PCR that distinguishes wild-type infections from vaccinations is a useful diagnostic tool, it has a different purpose than our real-time RT-PCR method, which is the first method designed to screen field samples for a wide range of BT viruses. Furthermore, the method developed in this study represents a great improvement over previous conventional (i.e., nonfluorogenic) RT-PCR methods, because it can be performed on a large scale to monitor virus circulation in animal populations. The sensitivity of the new assay was comparable to that of the established nested RT-PCR protocol (Fig.  1 ) that can detect 0.1 fg of BTV RNA. 2 This level of sensitivity is also comparable to virus isolation in embryonated chicken eggs, 2 which takes considerably longer to yield results. However, results of PCR-based BTV diagnosis, including the fluorogenic method described here, need to be interpreted with caution as BTV has been detected by RT-PCR from the blood of infected calves and sheep for at least 30 days, and sometimes longer (up to 90 days) after the virus isolation ceases to be positive. 5, 16, 21 Transmission of BTV by biting midges fed with this noninfectious blood, even though it is RT-PCR positive, is poor. 5, 16, 21 Thus detection of virus-specific nucleic acid by these methods indicates recent viral infection, but does not nec-essarily indicate the presence of contagious virus in the animal.
The data presented herein demonstrates that this new method is capable of detecting a wide range of BTV isolates, including those currently circulating in the western Mediterranean. However, 9 out of 24 reference BTV serotypes strains were not detected. Although EU reference strains of serotypes 4 and 16 were among those not detected, our assay did detect all 4 BTV-4 field isolates previously identified, 1 vaccine BTV-4 strain, and the only BTV-16 field isolate available. We determined the primer and probe sequence requirements for detection by comparing the gene segment 5 sequences between detected and undetected BTV strains. Although this region is fairly highly conserved, it does exhibit enough sequence variation among isolates to render some of them undetectable. Our investigation found that minor nucleotide changes within the probe region were more detrimental to detection by the assay than changes in the primer-binding region. It is important to note, however, that the fewest changes resulting in loss of signal included 1 mismatch within the probe region as well as 2 mismatches in the primer-binding region, whereas a single nucleotide mismatch within each of the primer-hybridizing regions did not cause loss of detection. The BTV-4 undetectable EU reference BTV-4 strain and the detectable vaccine strain differed only by 2 nucleotides within the target region, 1 of which is located in the probe-hybridizing region. The ability of this method to detect a majority of BTV serotypes is likely due to its detection of RNA segment 5, rather than segment 2, which contains the serotype determinant sequence. 27 It is noteworthy that all nondetected BTV variants had also been previously isolated from regions that were geographically or temporally distant (or both) from the variants currently circulating in the Mediterranean region.
Taken together, these results suggest that the development of a real-time RT-PCR with fluorogenic probes that is capable of detecting all BTV variants might not be an easy task. However, our assay is currently used as the standard to identify new BTV outbreaks and monitor the spread of epizootic infections in Spain. This approach can be adapted to other geographic locations by 1) identifying the local BTV variants circulating in the affected area, 2) obtaining sequence data from conserved regions (here we propose a short, conserved stretch within RNA segment 5) of the BTV variants identified, and 3) designing a set of primers and fluorogenic Taqman probe for real-time RT-PCR, taking into account that a single nucleotide mismatch in the probe-binding region could result in a dramatic loss of detection. In this regard, the use of an MGB group linked to the Taqman probe can be of great help, because it increases the binding strength of the probe to the nucleic acid, 18 allowing the selection of shorter target sequences. In this study, this approach was successful at detecting all BTV variants currently circulating in the western Mediterranean. Whether or not our assay could be applied to other BTV epizootics occurring in different parts of the world would depend on the nucleotide sequence similarity within the primer and probe-binding regions in RNA segment 5 of the BTV variant(s) involved. For instance, based on nucleotide sequence similarity, it is predicted that only 3 out of 5 US BTV prototype strains (BTV-11, -13, and -17) are likely to be detectable by our assay.
The specificity of the new real-time fluorogenic RT-PCR assay was further confirmed by the lack of detection of non-BTV orbiviruses (AHSV and EHDV) and phylogenetically unrelated viruses that cause similar symptoms to BTV (foot-and-mouth disease virus and contagious ecthyma virus). Consequently, this assay could be of great help in the differential diagnosis of bluetongue disease, once it is ascertained that BTV variants circulating in the affected region are detectable by this method.
The fluorogenic real-time RT-PCR assay described here yields levels of sensitivity and specificity comparable to virus isolation and conventional nested RT-PCR methods used for BTV nucleic acid detection. In addition, the new assay presents 2 major advantages over conventional nested RT-PCR methods. First, it can be used in large-scale screening because of its ability to simultaneously analyze up to 96 samples per run. In fact, the nucleic acid extraction protocol for 2 blocks of 96 samples can be carried out in less than 2 hours, which together with sample preparation and the time required for each real-time RT-PCR (2 hours 11 minutes), gives a processing capacity of 192 samples in approximately 6 hours. Currently, testing capacity in the authors' laboratories has been increased to up to 500 blood samples per day by using 2 real-time thermal cyclers working in parallel with 96-well plates. With a working scheme like this, testing capacity reached 2,600 samples per week in peak periods during the recent BTV outbreaks in Spain. Further optimization, including a fully automated system for nucleic acid extraction, and adaptation to a recently available 384-well format, is ongoing in the authors' laboratories and testing capacity is expected to reach 1,000 samples per day. Second, the real-time fluorogenic RT-PCR is less susceptible than nested RT-PCR to potential contamination problems, which often prevent many laboratories from using nested RT-PCR methods.
In summary, the real-time fluorogenic RT-PCR method developed and applied in this study represents a new analytical tool that allows large-scale monitor-ing of the introduction and spread of BTV in a large population of cattle and sheep at risk. This technique is currently being used to monitor BTV outbreaks in Spain.
